Today we announced the initiation of a phase 3 study for the prevention of chronic obstructive
pulmonary disease (COPD) exacerbations in adult patients with a history of them. Learn more about the trial: go.merck.com/~n3w
We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only.
FLS: merck.us/3TKXNuZ

